|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | ||
| Depreciation expense | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | ||
| Amortization of debt discounts issuance and warrants | ||
| Shares issued for services | ||
| Shares issued for interest expense | ||
| Change in value of warrant liabilities | ||
| Commitment shares issued for equity line of credit | ||
| Common shares issuance for services | ||
| Stock-based compensation | ||
| Amortization of non-cash prepaids | ||
| Accounts payable | ||
| Accrued expenses | ||
| Accrued interest on convertible notes | ||
| Accrued Payroll and payroll taxes | ||
| Net cash used in operating activities | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Patent License Acquisition | ||
| Net cash used in investing activities | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Prepaid warrants (net of fees) | ||
| Common stock issuance (net of fees) | ||
| Short-term borrowings | ||
| Short-term loan repayments | ||
| Sale of preferred stock | ||
| Initial public offering (net of fees) | ||
| Net proceeds from conversion of debt A, B, C, D, E & F | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash – beginning of period | ||
| Cash – end of period | ||
| NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
| Discount on notes payable – redemption premium | ||
| Dividends payable | ||
| Conversion of Make Whole Liability to common stock | ||
| Deemed dividend on Series A convertible preferred stock | ||
| Mezzanine equity conversion (net of costs) | ||
| Conversion of preferred stock to common stock | ||
| Amortization of deferred offering costs | ||
| Conversion of convertible notes into common stock | ||
| Conversion of warrants into common stock | ||
| Issuance of common stock to investor advisor – settlement | ||
| Conversion of make-whole liability to common stock | ||
| Clawback of common stock for over issuance | ||
| Common stock issued for patent purchase | ||
| Reclassification of warrants liability to equity | ||
| Shares issued for prepaid services |
Loading...
